Go to homepage
News & Publications
Toolkit gives you guidance in managing patients with chronic pain
e-Reports, Nov. 12, 2013
Font size: A  AIRSS feedRSSPrint
Untitled document

The Indiana Prescription Drug Abuse Task Force has launched a comprehensive toolkit to help you comply with the opioid prescribing emergency rules recently passed by the Medical Licensing Board of Indiana. The resource, First Do No Harm, provides detailed guidance for physicians who prescribe controlled substances.

“The toolkit is a collaborative project from a diverse group of providers throughout the state that provides recommendations to enhance the safe prescribing of opioids and the necessary resources to facilitate implementation in the busy doctor’s office – including templates and screening tools and even talking points for difficult conversations with patients,” explained ISMA member Deborah McMahan, M.D., who chaired the committee that developed the guidelines.

 McMahan  Trobridge
LEFT – Deborah McMahan, M.D., explains the importance of the Do No Harm toolkit during the Prescription Drug Abuse Symposium in Indianapolis. RIGHT – Drew Trobridge, M.D., discusses proper monitoring and counseling of chronic pain patients during a breakout session at the Nov. 1 symposium.

The guide provides 10 key prescribing recommendations for a patient-centered approach to all patients being treated for chronic pain. They include:

  • Performing your own evaluation
  • Conducting a risk stratification for all
  • Setting functional goals with your patients, including achievable targets for pain management
  • Utilizing evidence-based treatments, including non-opioid options initially, where possible
  • Discussing the potential risks and benefits of opioid treatment
  • Scheduling periodic visits with patients
  • Employing the 5 A’s: assess affect, ask about daily activities, provide analgesia, minimize adverse effects of treatment, monitor aberrant drug use behaviors
  • Using INSPECT, Indiana’s prescription drug monitoring program
  • Conducting urine drug tests
  • Taking action when a patient’s opioid dose reaches above 30 milligrams

Download the free toolkit here.

Copyright: Information written and displayed on www.ismanet.org is the property of ISMA and may not be reproduced without expressed written permission of the Indiana State Medical Association.

For a more detailed sitemap click here.